Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02428712
Title A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Fore Biotherapeutics
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Additional content available in CKB BOOST